O’Melveny Advises Honliv Healthcare in its Hong Kong IPO
July 13, 2020
FOR IMMEDIATE RELEASE
HONG KONG—July 13, 2020—O’Melveny advised Honliv Healthcare Management Group Company Limited (Honliv Health) in its IPO and listing today on the Hong Kong Stock Exchange. The IPO offering size was approximately HK$315 million (approximately US$41.3 million) prior to the exercise of the over-allotment option. Assuming full exercise of the over-allotment option, the offering size will be approximately HK$362 million (approximately US$46.7 million).
Honliv Health operates one of the largest for-profit private general hospitals in China, Henan Honliv Hospital. Located at Xinxiang City, Henan Province, Henan Honliv Hospital is the largest for-profit private general hospital in Central China. Among all the for-profit private general hospitals in China, Henan Honliv Hospital ranked third in terms of number of beds in operation as of December 31, 2019.
Partners Ke Geng and Ke Zhu led the O’Melveny team, with support from counsel Ye Sun and Wendy Kan, associate Katherine Wang, trainee solicitor Dave Chan, and legal consultant Liam Liu.
BOCOM International was the sole sponsor and lead underwriter. The joint global coordinators also included CMB International.
About O’Melveny
It’s more than what you do: it’s how you do it. Across sectors and borders, in board rooms and courtrooms, we measure our success by yours. And in our interactions, we commit to making your O’Melveny experience as satisfying as the outcomes we help you achieve. Our greatest accomplishment is ensuring that you never have to choose between premier lawyering and exceptional service. So, tell us. What do you want to achieve? Visit us at www.omm.com or learn more in our firm at-a-glance, year-end highlights, and on LinkedIn, Twitter, Facebook, Instagram, and YouTube.
Contact:
Christopher Rieck
O’Melveny & Myers LLP
+1 212 326 2218
crieck@omm.com
Chris Schob
O’Melveny & Myers LLP
+86 21 2307 7000
cschob@omm.com